Canada is the only country with a broad public health system that does not include universal, nationwide coverage for pharmaceuticals. This omission causes real hardship to those Canadians who are not well-served by the existing patchwork of limited provincial plans and private insurance. It also represents significant forgone benefits in terms of governments’ ability to…

Learn about the small, physician-led organizations that have supported Canadian medicare over the years. Understand their common characteristics and see how physicians might become better stewards of this important program in the future.

This article covers seven strategies that Israel uses to manage the costs of its national pharmaceutical program. Canada has much to learn from Israel if it hopes to expand Canadian medicare to include a pharmaceutical benefit for everyone.

Health systems have repeatedly addressed concerns about efficiency and equity by employing trans-national comparisons to draw out the strengths and weaknesses of specific policy initiatives. This paper demonstrates the potential for explicit historical analysis of waiting times for hospital treatment to add value to spatial comparative methodologies. As published in Health Economics, Policy and Law…